Cryocell International Stock Buy Hold or Sell Recommendation
| CCEL Stock | USD 8.67 0.42 4.62% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding CryoCell International is 'Strong Hold'. The recommendation algorithm takes into account all of CryoCell International's available fundamental, technical, and predictive indicators you will find on this site.
Check out CryoCell International Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide. Note, we conduct extensive research on individual companies such as CryoCell and provide practical buy, sell, or hold advice based on investors' constraints. CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
CryoCell |
Execute CryoCell International Buy or Sell Advice
The CryoCell recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CryoCell International. Macroaxis does not own or have any residual interests in CryoCell International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CryoCell International's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
CryoCell International Trading Alerts and Improvement Suggestions
| CryoCell International appears to be risky and price may revert if volatility continues | |
| CryoCell International currently holds 10.9 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about CryoCell International's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 31.34 M. Net Loss for the year was (9.52 M) with profit before overhead, payroll, taxes, and interest of 21.54 M. | |
| CryoCell International has a poor financial position based on the latest SEC disclosures | |
| About 48.0% of CryoCell International shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 10000 shares by Oleg Mikulinsky of CryoCell International at 4.34 subject to Rule 16b-3 |
CryoCell International Returns Distribution Density
The distribution of CryoCell International's historical returns is an attempt to chart the uncertainty of CryoCell International's future price movements. The chart of the probability distribution of CryoCell International daily returns describes the distribution of returns around its average expected value. We use CryoCell International price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CryoCell International returns is essential to provide solid investment advice for CryoCell International.
| Mean Return | 0.65 | Value At Risk | -4.42 | Potential Upside | 7.14 | Standard Deviation | 4.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CryoCell International historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
CryoCell Stock Institutional Investors
| Shares | Bank Of America Corp | 2024-06-30 | 57.0 | Jpmorgan Chase & Co | 2024-06-30 | 11.0 | Rowland & Co Investment Counsel | 2024-09-30 | 0.0 | Wells Fargo & Co | 2024-06-30 | 0.0 | Hamilton Lane Advisors Llc | 2024-09-30 | 409.7 K | Sfi Advisors, Llc | 2024-06-30 | 165.3 K | Vanguard Group Inc | 2024-09-30 | 116.8 K | Massmutual Trust Co Fsb/adv | 2024-09-30 | 111 K | Geode Capital Management, Llc | 2024-09-30 | 39.9 K | Northern Trust Corp | 2024-09-30 | 21.8 K | Hpm Partners Llc | 2024-06-30 | 19.6 K |
CryoCell International Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 3.8M | (2.1M) | (6.6M) | (1.3M) | (1.2M) | (1.1M) | |
| Free Cash Flow | 8.0M | 974.9K | (8.6M) | 1.3M | 1.5M | 1.2M | |
| Depreciation | 636.0K | 1.3M | 1.8M | 1.7M | 2.0M | 2.1M | |
| Other Non Cash Items | 1.1M | 1.0M | 1.0M | 16.7M | 19.2M | 20.1M | |
| Capital Expenditures | 450.0K | 7.0M | 17.2M | 7.6M | 8.8M | 9.2M | |
| Net Income | 3.6M | 2.1M | 2.8M | (9.5M) | (10.9M) | (10.4M) | |
| End Period Cash Flow | 10.4M | 8.3M | 1.7M | 406.1K | 467.0K | 443.6K | |
| Change To Inventory | 454.9K | 210.3K | 490.0K | 360.4K | 324.4K | 264.9K | |
| Investments | 457.4K | (7.0M) | (15.3M) | (8.1M) | (7.3M) | (7.0M) | |
| Change To Netincome | 1.2M | 365.2K | (397.4K) | (274.3K) | (246.9K) | (234.6K) | |
| Net Borrowings | 5.5M | (4.1M) | (3.1M) | 9.3M | 8.4M | 8.8M |
CryoCell International Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CryoCell International or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CryoCell International's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CryoCell stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.62 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 4.83 | |
Ir | Information ratio | 0.11 |
CryoCell International Volatility Alert
CryoCell International currently demonstrates below-average downside deviation. It has Information Ratio of 0.11 and Jensen Alpha of 0.62. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CryoCell International's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CryoCell International's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.CryoCell International Fundamentals Vs Peers
Comparing CryoCell International's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CryoCell International's direct or indirect competition across all of the common fundamentals between CryoCell International and the related equities. This way, we can detect undervalued stocks with similar characteristics as CryoCell International or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of CryoCell International's fundamental indicators could also be used in its relative valuation, which is a method of valuing CryoCell International by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CryoCell International to competition |
| Fundamentals | CryoCell International | Peer Average |
| Return On Equity | 1.29 | -0.31 |
| Return On Asset | -0.0013 | -0.14 |
| Profit Margin | (0.28) % | (1.27) % |
| Operating Margin | 0.17 % | (5.51) % |
| Current Valuation | 82.89 M | 16.62 B |
| Shares Outstanding | 8.06 M | 571.82 M |
| Shares Owned By Insiders | 47.71 % | 10.09 % |
| Shares Owned By Institutions | 11.10 % | 39.21 % |
| Number Of Shares Shorted | 9.45 K | 4.71 M |
| Price To Earning | 10.76 X | 28.72 X |
| Price To Book | 9.72 X | 9.51 X |
| Price To Sales | 2.30 X | 11.42 X |
| Revenue | 31.34 M | 9.43 B |
| Gross Profit | 21.54 M | 27.38 B |
| EBITDA | (10.42 M) | 3.9 B |
| Net Income | (9.52 M) | 570.98 M |
| Cash And Equivalents | 2.96 M | 2.7 B |
| Cash Per Share | 0.35 X | 5.01 X |
| Total Debt | 10.9 M | 5.32 B |
| Debt To Equity | 0.26 % | 48.70 % |
| Current Ratio | 0.47 X | 2.16 X |
| Book Value Per Share | (1.19) X | 1.93 K |
| Cash Flow From Operations | 8.92 M | 971.22 M |
| Short Ratio | 0.40 X | 4.00 X |
| Earnings Per Share | (1.07) X | 3.12 X |
| Target Price | 9.0 | |
| Number Of Employees | 82 | 18.84 K |
| Beta | 0.51 | -0.15 |
| Market Capitalization | 73.29 M | 19.03 B |
| Total Asset | 61.22 M | 29.47 B |
| Retained Earnings | (31.16 M) | 9.33 B |
| Working Capital | (11.41 M) | 1.48 B |
| Current Asset | 6.08 M | 9.34 B |
Note: Disposition of 10000 shares by Oleg Mikulinsky of CryoCell International at 4.34 subject to Rule 16b-3 [view details]
CryoCell International Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CryoCell . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About CryoCell International Buy or Sell Advice
When is the right time to buy or sell CryoCell International? Buying financial instruments such as CryoCell Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CryoCell International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out CryoCell International Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Earnings Share (1.07) | Revenue Per Share 3.89 | Quarterly Revenue Growth 0.025 | Return On Assets (0) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.